Skip to main content
. 2020 Oct 1;33(6):652–657. doi: 10.1016/j.jpag.2020.09.004

Table 2.

Frequency of Documented Sexual Health Counseling and Contraception Use Across Patient Characteristics

Characteristic Documented Sexual Health Counseling
Contraception Use
n (%) P value n (%) P value
Age, y .011 .581
 15-20 (n = 80) 19 (23.8) 37 (46.3)
 21-25 (n = 77) 33 (42.9) 39 (50.6)
Race .070 .778
 Asian (n = 11) 1 (9.1) 6 (54.5)
 Black or African American (n = 13) 3 (23.1) 6 (46.2)
 White or Caucasian (n = 110) 36 (32.7) 55 (50.0)
 Other/not specified (n = 23) 12 (52.2) 9 (39.1)
Ethnicity .001 .987
 Hispanic or Latino (n = 29) 17 (58.6) 14 (48.3)
 Not Hispanic or Latino (n = 128) 35 (27.3) 62 (48.4)
Marital Status .340 .508
 Married/other (n = 16) 7 (43.8) 9 (56.3)
 Single (n = 141) 45 (31.9) 67 (47.5)
Cancer Type .595 .785
 Breast (n = 9) 3 (33.3) 4 (44.4)
 Gynecologic (n = 8) 2 (25.0) 5 (62.5)
 Hematologic (n = 64) 21 (32.8) 29 (45.3)
 Neurologic (n = 15) 3 (20.0) 7 (46.7)
 Sarcoma (n = 8) 4 (50.0) 6 (75.0)
 Thyroid (n = 49) 19 (38.8) 23 (46.9)
 Other (n = 4) 0 (0.0) 2 (50.0)
Surgery .775 .824
 Yes (n = 82) 28 (34.1) 39 (47.6)
 No (n = 75) 24 (32.0) 37 (49.3)
Chemotherapy .594 .741
 Yes (n = 95) 33 (34.7) 47 (49.5)
 No (n = 62) 19 (30.6) 29 (46.8)
Radiation .532 .824
 Yes (n = 82) 29 (35.4) 39 (47.6)
 No (n = 75) 23 (30.7) 37 (49.3)
Bone marrow transplant .441 1.000
 Yes (n = 8) 4 (50.0) 4 (50.0)
 No (n = 149) 48 (32.2) 72 (48.3)
Hormone therapy .686 .713
 Yes (n = 7) 3 (42.9) 4 (57.1)
 No (n = 150) 49 (32.7) 72 (48.0)
Targeted/biologic therapy .314 .852
 Yes (n = 28) 7 (25.0) 14 (50.0)
 No (n = 129) 45 (34.9) 62 (48.1)
Prior pregnancy .010 .682
 Yes (n = 13) 9 (69.2) 7 (53.8)
 No (n = 144) 43 (29.9) 69 (47.9)
Sexual activity .327 .000
 Yes (n = 56) 23 (41.1) 39 (69.6)
 No (n = 56) 18 (32.1) 20 (35.7)
Documented sexual health counseling 0.003
 Yes (n = 52) 34 (65.4)
 No (n = 105) 42 (40.0)

Unadjusted comparisons, P values based on Pearson χ2 and Fisher exact tests.